Checkpoint Capital L.P. PHAT Holdings History
Checkpoint Capital L.P.'s Phathom Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Checkpoint Capital L.P. held - shares of Phathom Pharmaceuticals Inc(PHAT), totaling N/A. This investment constitutes 0% of their stock portfolio, and Checkpoint Capital L.P. now holds 0% of the outstanding Phathom Pharmaceuticals Inc(PHAT) stock.
The initial trade took place in 2023Q4. And since then Checkpoint Capital L.P. has made 4 purchases of PHAT, at an average price of $11.67, for a total of 2.27 Mil shares. In addition, there have been 1 sales at an average price of $6.07 for 2.27 Mil shares. Based on historical transaction data and PHAT's current price of $8.26, Checkpoint Capital L.P.'s estimated gain on his PHAT holdings is $-12.72 Mil, reflecting a -47.96% gain to date.
Checkpoint Capital L.P. PHAT ($8.26) Holding Chart
Checkpoint Capital L.P. PHAT ($8.26) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
